日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dealing with the Verteporfin Shortage: Treatment Options and Outcomes in Patients with Chronic and Non-Resolving Central Serous Chorioretinopathy

应对维替泊芬短缺:慢性及难治性中心性浆液性脉络膜视网膜病变患者的治疗选择及预后

van den Tillaart, Femke M; Hartgers, Franca; Hoyng, Carel B; Yzer, Suzanne

Ursodeoxycholic Acid for Trans Intestinal Cholesterol Excretion Stimulation: A Randomized Placebo Controlled Crossover Study

熊去氧胆酸促进经肠道胆固醇排泄:一项随机、安慰剂对照交叉研究

Oostveen, Reindert F; Kaiser, Yannick; Hartgers, Merel L; Meessen, Emma C E; Grefhorst, Aldo; Hovingh, G Kees; Kuipers, Folkert; Stroes, Erik S G; Groen, Albert K; Reeskamp, Laurens F

PREDNISOLONE EYE DROPS AS A POTENTIAL TREATMENT IN NONNEOVASCULAR PACHYCHOROID-RELATED DISEASES

泼尼松龙滴眼液作为非血管性厚脉络膜相关疾病的潜在治疗方法

van den Tillaart, Femke M; Temmerman, Irene M; Hartgers, Franca; Yzer, Suzanne

Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma

三氟尿苷/替吡嘧啶联合伊立替康治疗晚期难治性胆道癌患者的II期临床试验

Tella, Sri Harsha; Foster, Nathan; Qian, Shi; Nguyen, Tran; Borad, Mitesh J; McWilliams, Robert R; Alberts, Steven R; Wee Ma, Wen; Chakrabarti, Sakti; Fruth, Briant; Wessling, Jaclynn; Hartgers, Mindy; Washburn, Leslie; Fernandez-Zapico, Martin E; Hogenson, Tara L; Pitot, Henry; Jin, Zhaohui; Mahipal, Amit

Reducing carbon footprint by switching to reusable soft-mist inhalers

改用可重复使用的软雾吸入器,从而减少碳足迹

Janson, Christer; Hernando Platz, Jaime; Soulard, Stéphane; Langham, Sue; Nicholson, Lindsay; Hartgers-Gubbels, Elisabeth Sophia

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

全球纯合子家族性高胆固醇血症的经验:回顾性队列研究

Tromp, Tycho R; Hartgers, Merel L; Hovingh, G Kees; Vallejo-Vaz, Antonio J; Ray, Kausik K; Soran, Handrean; Freiberger, Tomas; Bertolini, Stefano; Harada-Shiba, Mariko; Blom, Dirk J; Raal, Frederick J; Cuchel, Marina

Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs

吸气峰值流量不足和严重吸气错误与慢性阻塞性肺病相关医疗保健成本升高有关

Leving, Marika T; van Boven, Job F M; Bosnic-Anticevich, Sinthia Z; van Cooten, Joyce; Correia de Sousa, Jaime; Cvetkovski, Biljana; Dekhuijzen, Richard; Dijk, Lars; García Pardo, Marina; Gardev, Asparuh; Gawlik, Radosław; van der Ham, Iris; Hartgers-Gubbels, Elisabeth Sophia; Janse, Ymke; Lavorini, Federico; Maricoto, Tiago; Meijer, Jiska; Metz, Boyd; Price, David B; Roman-Rodríguez, Miguel; Schuttel, Kirsten; Stoker, Nilouq; Tsiligianni, Ioanna; Usmani, Omar S; Kocks, Janwillem H

Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]

价值内幕 第一季 第一集:支付方和 HTA 的重要性:我们是如何走到这一步的?(价值简介)[播客]

Drummond, Michael F; Hartgers-Gubbels, Elisabeth Sophia; Chambers, Michael

Value Insider Season 1 Episode 2: How to Measure Quality of Life and Utility? (QoL) [Podcast]

价值内幕 第一季 第二集:如何衡量生活质量和效用?(QoL)[播客]

Devlin, Nancy J; Hartgers-Gubbels, Elisabeth Sophia; Chambers, Michael

Value Insider Season 1 Episode 3: How Does Budget Impact and Affordability in Healthcare Work? (BI and Affordability) [Podcast]

《价值内幕》第一季第三集:医疗保健领域的预算影响和可负担性如何运作?(预算影响和可负担性)[播客]

Sullivan, Sean D; Hartgers-Gubbels, Elisabeth Sophia; Chambers, Michael